Literature DB >> 3297883

Hyperglycemia decreases glucose uptake in type I diabetes.

H Yki-Järvinen, E Helve, V A Koivisto.   

Abstract

It has recently been postulated that hyperglycemia per se may contribute to insulin resistance in diabetes. To examine this possibility directly, we measured glucose uptake after 24 h of hyperglycemia (281 +/- 16 mg/dl) and normoglycemia (99 +/- 6 mg/dl) in 10 type I (insulin-dependent) diabetic patients (age 33 +/- 3 yr, relative body wt 102 +/- 3%) treated with continuous subcutaneous insulin infusion. Hyperglycemia was induced by an intravenous glucose infusion, whereas saline was administered during the control day. During both studies the patient received a similar diet and insulin dose. After hyper- and normoglycemia, a primed continuous infusion of insulin (40 mU X m-2 X min-1) was started, and plasma glucose was adjusted to and maintained at 142 +/- 2 and 140 +/- 2 mg/dl, respectively, during 60-160 min of insulin infusion. The rate of glucose uptake after hyperglycemia averaged 8.3 +/- 1.1 mg X kg-1 X min-1, which was lower than the rate after the normoglycemic period (10.1 +/- 1.2 mg X kg-1 X min-1, P less than .001). In conclusion, short-term hyperglycemia reduces glucose uptake in type I diabetic patients. Thus, part of the glucose or insulin resistance in these patients may be caused by hyperglycemia per se.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3297883     DOI: 10.2337/diab.36.8.892

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  58 in total

Review 1.  Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance.

Authors:  A Virkamäki; K Ueki; C R Kahn
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

2.  High-intensity exercise and carbohydrate-reduced energy-restricted diet in obese individuals.

Authors:  Francesco Sartor; Helma M de Morree; Verena Matschke; Samuele M Marcora; Athanasios Milousis; Jeanette M Thom; Hans-Peter Kubis
Journal:  Eur J Appl Physiol       Date:  2010-07-14       Impact factor: 3.078

Review 3.  Protein O-GlcNAcylation in diabetes and diabetic complications.

Authors:  Junfeng Ma; Gerald W Hart
Journal:  Expert Rev Proteomics       Date:  2013-08       Impact factor: 3.940

4.  In vivo activation of ROCK1 by insulin is impaired in skeletal muscle of humans with type 2 diabetes.

Authors:  Kwang-Hoon Chun; Kang-Duk Choi; Dae-Ho Lee; Yoonshin Jung; Robert R Henry; Theodore P Ciaraldi; Young-Bum Kim
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-12-28       Impact factor: 4.310

5.  Minimal model analysis of insulin sensitivity and glucose-mediated glucose disposal in type 1 (insulin-dependent) diabetic pancreas allograft recipients.

Authors:  K Osei; D A Cottrell; M L Henry; R J Tesi; R M Ferguson; T M O'Dorisio
Journal:  Diabetologia       Date:  1992-07       Impact factor: 10.122

Review 6.  Role of insulin resistance in the pathogenesis of NIDDM.

Authors:  H Yki-Järvinen
Journal:  Diabetologia       Date:  1995-12       Impact factor: 10.122

7.  Regulation of the GLUT1 glucose transporter in cultured myocytes: total number and subcellular distribution as determined by photoaffinity labelling.

Authors:  I M el-Kebbi; S Roser; R J Pollet; S W Cushman; C M Wilson
Journal:  Biochem J       Date:  1994-07-01       Impact factor: 3.857

8.  In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats.

Authors:  L Rossetti; M Hawkins; W Chen; J Gindi; N Barzilai
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

9.  Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes.

Authors:  R C Bonadonna; S Del Prato; M P Saccomani; E Bonora; G Gulli; E Ferrannini; D Bier; C Cobelli; R A DeFronzo
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

10.  Leptin deficiency causes insulin resistance induced by uncontrolled diabetes.

Authors:  Jonathan P German; Brent E Wisse; Joshua P Thaler; Shinsuke Oh-I; David A Sarruf; Kayoko Ogimoto; Karl J Kaiyala; Jonathan D Fischer; Miles E Matsen; Gerald J Taborsky; Michael W Schwartz; Gregory J Morton
Journal:  Diabetes       Date:  2010-04-27       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.